Aspire Biotech, Inc. was founded in 2001 by a group of experienced biomaterial scientists and medical device engineers. We are a biomaterials R & D company focused on improving medical devices through the development of superior biomaterials. Our core competencies surround the development, formulation, testing, and application of specialty biomaterials.

Innovations by the Aspire team have led to the development of several multi-million dollar products in a variety of medical markets. We have made critical contributions to the development of wound closure systems, gastrointestinal testing systems, wound and tissue sealants, skin protectants, and veterinary tissue adhesives.

Our Quality Managment System is certified according to ISO 13485:2016 by NQA (Global Certification Body accredited by ANAB). We are registered with the FDA and also compliant under QSR (21 CFR Part 820). Aspire has significant experience working under quality control regulations and standards, as well as supporting submissions to the FDA. 

Quality Policy Statement

"We commit to Exceed Customer Expectations and Meet Regulatory Requirements by Maintaining Quality System Effectiveness, Innovation, and Service"